Karo Bio AB Announces Rights Issue of MSEK 38.7 and Calls an Extraordinary General Meeting  
10/24/2012 8:39:30 AM

The Board of Directors of Karo Bio has decided to convene an Extraordinary General Meeting on November 19, 2012 and there present a proposal to implement a rights issue of approximately MSEK 38.7 with preferential rights for existing shareholders. The purpose of the issue is to secure funding that will allow the company to achieve a neutral cash flow, which is expected to be within reach in 2013.